Categories: News

Sentry unveils new 340B BI reporting solution, the most powerful analytics tool on the market

DEERFIELD BEACH, Fla., May 19, 2021 /PRNewswire/ — Sentry Data Systems, Inc., the nation’s leader in pharmacy procurement, compliance and utilization management, today introduced the 340B BI tool as a breakthrough for customers who need more transparency from their data to counter increased complexity in their 340B programs. Sentry 340B BI seamlessly integrates with its customers’ continuously updated data — including ordering platforms — and is designed to allow even non-experts to run advanced business intelligence reports.

Sentry 340B BI is designed to allow even non-experts to run advanced business intelligence reports.

“Sentry 340B BI changes the game by providing easy access to sophisticated, robust data sets, dashboards and reporting that uncover valuable insights to help covered entities maximize their benefits,” said Travis Leonardi, RPh, founder and CEO of Sentry Data Systems. “By being fully customizable and easy to use, our new solution goes beyond anything offered by our competitors and represents the next level in analytics reporting for our customers.”

Sentry 340B BI aggregates customers’ data and populates it into an easy-to-use analytics and reporting environment. It’s a highly flexible, advanced solution designed to be readily accessible, with drag-and-drop functionality – without the need to enlist a consultant or analyst to write queries or build reports. The result is a robust visualization of a customer’s 340B program.

The tool is designed to integrate seamlessly with Sentry’s 340B platform, with the abilities to roll up numbers from mixed-use and contract pharmacy settings, and easily compare pharmacy data at an enterprise level. It allows for nearly limitless manipulation of information, with the ability to search and arrange data by drug manufacturer, NDC number and location, among other fields, to yield metrics on key concerns such as drug spending, claims volume, dispensations and revenue.

For covered entities, the new 340B BI tool has powerful applications for managing audits, changes from drug manufacturers, vertical integration and hospital consolidation.

About Sentry Data Systems, Inc.
Sentry Data Systems, Inc. is a pioneer in providing technology solutions that help healthcare providers address their three biggest challenges: reducing total cost of care, managing compliance and producing better quality. Thousands of hospitals and care locations across the country rely on Sentry’s integrated platform for their solutions, which provide decision support for millions of unique patients and have helped hospital systems and IDNs realize billions of dollars in documented savings.

Media Contact:
Michelle Hornberger, MHSA, FACHE
Vice President of Marketing
mhornberger@sentryds.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/sentry-unveils-new-340b-bi-reporting-solution-the-most-powerful-analytics-tool-on-the-market-301294459.html

SOURCE Sentry Data Systems, Inc.

Staff

Recent Posts

Teknova Announces Closing of $15.4 Million Private Placement

HOLLISTER, Calif., July 12, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a…

1 day ago

Faith In Young Champions: Hisense Partners with UEFA Foundation to Bring the Beautiful Game to Hospitalized Children

QINGDAO, China, July 12, 2024 /PRNewswire/ -- During the EURO 2024 tournament, the global home…

2 days ago

JANONE CONFIRMS NAME CHANGE TO ALT5 SIGMA CORPORATION AND NEW TICKER SYMBOL TO ALTS

LAS VEGAS, July 12, 2024 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a multidisciplinary organization with…

2 days ago

Hospital Español Auxilio Mutuo De Puerto Rico, Inc. Reports Network Breach

Important Notice About a Privacy MatterSAN JUAN, PUERTO RICO / ACCESSWIRE / July 12, 2024…

2 days ago

Nano Labs Announces Receipt of Deficiency Letters from Nasdaq

HANGZHOU, China, July 12, 2024 /PRNewswire/ -- Nano Labs Ltd (Nasdaq: NA) ("we," the "Company" or…

2 days ago

Inhance Technologies’ Statement in Response to EPA’s Section 6 Approach on Fluorination of Plastic Containers

HOUSTON, July 12, 2024 /PRNewswire/ -- Inhance Technologies welcomes the opportunity to engage with the…

2 days ago